Intellectual Property Owners Association Webinar Series - Skinny Labels and Inducing Infringement after GSK v. Teva

Friday, November 06, 2020 - Friday, November 06, 2020
2:00 pm New York - 3:00 pm New York
Webinar Series

Bruce M. Wexler, Partner and Global Co-Chair, Intellectual Property at Paul Hastings LLP, is proud to speak on Skinny Labels and Inducing Infringement after GSK v. Teva as part of the Intellectual Property Owners Association’s Webinar series, taking place virtually on November 5, 2020. In this webinar, Bruce and fellow presenters, including a patent litigator representing generic companies and a patent prosecutor, dive deep into the Federal Circuit’s precedential decision in GlaxoSmithKline v. Teva Pharmaceuticals and explore the potentially far-reaching impact for Hatch-Waxman and biosimilar litigation, as well as for research agendas and patent prosecution. Topics to be discussed include skinny labeling, “biological equivalence” and covered uses, and a potential increase in value for method-of-use patents.